Get started
Author

Lanetta B. Jordan

Management of Sickle Cell Disease
2014 · Barbara P. Yawn, George R. Buchanan, et al. · JAMA · 1,600
Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members
2015 · Barbara P. Yawn, George R. Buchanan, et al. · Survey of Anesthesiology · 261
Renal medullary carcinoma and sickle cell trait: A systematic review
2015 · Ofelia Alvarez, Maria M. Rodriguez, et al. · Pediatric Blood & Cancer · 93
Systematic Review of Transition From Adolescent to Adult Care in Patients With Sickle Cell Disease
2013 · Lanetta Jordan, Paul Swerdlow, et al. · Journal of Pediatric Hematology/Oncology · 86
Public Health Implications of Sickle Cell Trait
2011 · Althea M. Grant, Christopher S. Parker, et al. · American Journal of Preventive Medicine · 52
PDF
State-based surveillance for selected hemoglobinopathies
2014 · Mary M. Hulihan, Lisa Feuchtbaum, et al. · Genetics in Medicine · 47
PDF
Evidence gaps in the management of sickle cell disease: A summary of needed research
2015 · William J. Savage, George R. Buchanan, et al. · American Journal of Hematology · 43
Screening U.S. College Athletes for Their Sickle Cell Disease Carrier Status
2011 · Lanetta B. Jordan, Kim Smith-Whitley, et al. · American Journal of Preventive Medicine · 42
PDF
Frequently asked questions by hospitalists managing pain in adults with sickle cell disease
2011 · Wally R. Smith, Lanetta B. Jordan, et al. · Journal of Hospital Medicine · 35
Persistence and compliance of deferoxamine versus deferasirox in Medicaid patients with sickle-cell disease
2011 · L. B. Jordan, F. Vekeman, et al. · Journal of Clinical Pharmacy and Therapeutics · 29
PDF
Multicenter COMPACT study of COMplications in Patients with sickle cell disease And utilization of iron Chelation Therapy
2014 · Lanetta Jordan, Patricia Adams-Graves, et al. · Current Medical Research and Opinion · 9
Sickle cell disease--the American saga.
2013 · Azfar-E-Alam Siddiqi, Lanetta B Jordan, et al. · PubMed · 8
Practice Guideline for Pulmonary Hypertension in Sickle Cell: Direct Evidence Needed before Universal Adoption
2014 · Kathryn L. Hassell, Araba Afenyi-Annan, et al. · American Journal of Respiratory and Critical Care Medicine · 1
PRACTITIONER APPLICATION: Sickle Cell Hospital Unit: A Disease-Specific Model
2008 · Lanetta Jordan · Journal of Healthcare Management · 1
High Utilizers Of Health Care Resources: Results From The Multicenter Compact Study Of Complications In Patients With Sickle Cell Disease And Utilization Of Iron Chelation Therapy
2014 · L. Jordan, P. Adams-Graves, et al. · Value in Health
High Resource Utilizers From The Multicenter Compact Study Of Complications In Patients With Sickle Cell Disease and Utilization Of Iron Chelation Therapy
2013 · Lanetta B Jordan, Patricia Adams-Graves, et al. · Blood
Key cost drivers in the cost of care for sickle cell disease patients: Results of a systematic literature search and a survey of payers and key opinion leaders
2013 · L. Jordan, M.S. Duh, et al. · Value in Health
Final Results From the Multicenter Compact Study of Complications in Patients with Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review.
2012 · Lanetta B Jordan, Patricia Adams-Graves, et al. · Blood
Persistence and Compliance of Deferoxamine Versus Deferasirox in Medicaid Patients with Sickle-Cell Disease.
2009 · Lanetta B Jordan, Francis Vekeman, et al. · Blood
Asthma IN SICKLE CELL DISEASE as A RISK FACTOR for Acute Chest Syndrome IN Pediatric PATIENTS.
2009 · Andrea P Borns, Kristy Marquez, et al. · Blood
Works count: 20
Citation count: 2,306
H-index: 10
I10-index: 10
Year
Topic
Type